Dual specificity kinase DYRK3 regulates cell migration by influencing the stability of protrusions
Martina Ramella,
Lucrezia Maria Ribolla,
Sara Surini,
Kristyna Sala,
Diletta Tonoli,
Jean-Michel Cioni,
Arpan Kumar Rai,
Lucas Pelkmans,
Ivan de Curtis
Affiliations
Martina Ramella
Università Vita-Salute San Raffaele, 20132 Milan, Italy; Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Lucrezia Maria Ribolla
Università Vita-Salute San Raffaele, 20132 Milan, Italy; Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Sara Surini
Università Vita-Salute San Raffaele, 20132 Milan, Italy; Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Kristyna Sala
Università Vita-Salute San Raffaele, 20132 Milan, Italy; Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Diletta Tonoli
Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Jean-Michel Cioni
RNA Biology of the Neuron Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
Arpan Kumar Rai
Department of Molecular Life Sciences, University of Zurich, 8057 Zurich, Switzerland
Lucas Pelkmans
Department of Molecular Life Sciences, University of Zurich, 8057 Zurich, Switzerland
Ivan de Curtis
Università Vita-Salute San Raffaele, 20132 Milan, Italy; Cell Adhesion Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; Corresponding author
Summary: Plasma membrane-associated platforms (PMAPs) form at specific sites of plasma membrane by scaffolds including ERC1 and Liprin-α1. We identify a mechanism regulating PMAPs assembly, with consequences on motility/invasion. Silencing Ser/Thr kinase DYRK3 in invasive breast cancer cells inhibits their motility and invasive capacity. Similar effects on motility were observed by increasing DYRK3 levels, while kinase-dead DYRK3 had limited effects. DYRK3 overexpression inhibits PMAPs formation and has negative effects on stability of lamellipodia and adhesions in migrating cells. Liprin-α1 depletion results in unstable lamellipodia and impaired cell motility. DYRK3 causes increased Liprin-α1 phosphorylation. Increasing levels of Liprin-α1 rescue the inhibitory effects of DYRK3 on cell spreading, suggesting that an equilibrium between Liprin-α1 and DYRK3 levels is required for lamellipodia stability and tumor cell motility. Our results show that DYRK3 is relevant to tumor cell motility, and identify a PMAP target of the kinase, highlighting a new mechanism regulating cell edge dynamics.